GFRA4 and medullary thyroid gland carcinoma: In contrast, medullary thyroid carcinoma (MTC), a well-differentiated NEN, has prompted the identification of a highly specific target, GFRα4, demonstrating the need for a tailored approach based on the unique molecular landscape of each NEN subtype.